Longevity News

Woven dECM yarn scaffolds enable volumetric muscle loss regeneration via immunomodulation

Source: Nature - Biotechnology • Published: 29 Aug 2026, 00:00

Woven dECM yarn scaffolds enable volumetric muscle loss regeneration via immunomodulation

Describes a woven decellularized extracellular matrix yarn scaffold that restructures scaffold architecture to promote volumetric muscle loss regeneration via immune and tissue remodeling.

Key Takeaways
  • 3D woven dECM yarn scaffold enabled full interconnectivity and high porosity for implanted scaffolds
  • In murine VML models the scaffold improved vascularization, innervation, muscle mass, and strength restoration
  • Single-nucleus RNA-seq showed reduced SPP1+ neutrophils and increased CD206+/IGF-1+ macrophages driving IGF-1R signaling
Read Original Source

Continue exploring

Related longevity signals

Fight Aging!An Adiponectin Receptor Agonist Promotes Muscle Growth in RatsA short primer on a preclinical research article testing a small‑molecule adiponectin receptor agonist as a potential way to stimulate muscle growth and function in rodent models, useful for readers curious about emerging pharmacological strategies against muscle atrophy.Nature - BiotechnologyVirus-like particles enable targeted gene engineering and pooled CRISPR screening in primary human myeloid cellsA methods-focused article describing a virus-like particle toolkit for delivering diverse CRISPR edits and enabling pooled functional genomics in primary human myeloid cells.Nature - BiotechnologyMultiscale evaluation of collagen-stimulating materials: linking physicochemical properties to dermal regeneration outcomesAnalysis compares physicochemical features of common collagen‑stimulating particles and links those features to fibroblast, macrophage, and collagen remodeling outcomes.Nature - BiotechnologyDroplet digital PCR reveals that transgene copy number determines lifespan in SOD1G93A ALS miceA methods-focused research article examining how a precise DNA quantification technique maps transgene copy variation to disease trajectory in an ALS mouse model.